Ndrihi6vqzwv8zpac2kk aurelia

Aurelia Bioscience Ltd

ic No Reviews Yet
ic No Completed Orders
Nottingham, GB

About Aurelia Bioscience Ltd

Aurelia Bioscience Ltd is a contract research organisation that provides services in biological assay development, biological screening and laboratory equipment consultancy to SMEs, universities, medical charities, pharmaceutical companies and screening equipment manufacturers as part of the early... Show more »

Aurelia Bioscience Ltd is a contract research organisation that provides services in biological assay development, biological screening and laboratory equipment consultancy to SMEs, universities, medical charities, pharmaceutical companies and screening equipment manufacturers as part of the early (pre-clinical) phase of the drug discovery process. Types of work will include fee-for-service bioassay development;fee-for-service compound screening; more specialised 'novel' assay development; medium to high-throughput compound screening (thousands to tens of thousands); screening cascade development i.e. multiple assays to add value to compound hits with, for example, a chemistry company; equipment consultancy with equipment manufacturers who wish to validate prototype equipment for commercial release.

Scientists at Aurelia Bioscience Ltd have over 100 years experience in drug discovery gained at several blue chip pharmaceutical companies including Hoffmann La Roche, Smith Kline Beecham, Glaxo-Wellcome, AstraZeneca, ICI and UCB.

They have worked in pre-clinical discovery, designing and developing low, medium and high throughput assays for hits-to-lead, lead identification and lead optimisation drug discovery phases in both cellular and non-cellular assay formats. They have experience of a wide range of technologies designed to prosecute these activities in a scalable manner whilst bringing to bear technological developments that have the ability to probe ever further into the molecular interactions from which the drugs of the future may be identified.

Research areas worked in include respiratory disease, inflammatory disease, oncology, CNS-pain, rare disorders and diabetes, working on a range of molecular targets in these areas.

Show less

Diversity Certificates

Small business

Our Services (25)


ic

Corning® EPIC® Label-Free Screening Assays

Price on request

Our scientists have in-depth experience of label-free technology applied to cell-based assays gained over the past 6 years using Corning Epic, PerkinElmer EnSpire and SRU Bioscience Bind instruments.

These systems incorporate an optical biosensor into a micro-titre plate to measure the cellular response to a stimulus.... Show more »

Our scientists have in-depth experience of label-free technology applied to cell-based assays gained over the past 6 years using Corning Epic, PerkinElmer EnSpire and SRU Bioscience Bind instruments.

These systems incorporate an optical biosensor into a micro-titre plate to measure the cellular response to a stimulus. Specifically, the systems are able to detect changes in mass at the sensor surface resultant from alterations in cell shape and/or protein recruitment or migration to/from the membrane.

The technology is generic being independent of signaling pathway, it is non-invasive (no molecular biology required) and generates a kinetic response over seconds, minutes or hours resulting in an information rich readout.
Label-Free Screening

Label-free techniques are highly suitable for measuring responses in native or physiologically relevant systems such as primary human and animal cells without the need for over-expression or amplification through genetic modifications. This is of great benefit in understanding the molecular pharmacology of a receptor in its native environment, whereas a recombinant system does not necessarily have the natural coupling or utilise the correct signaling pathway.

Label-free techniques may also be of benefit where there is no simple/standard biological readout e.g. for de-orphanisation of receptors and identification of pharmacological “tool” compounds.

Show less

ic

Fluorescence Imaging Plate Reader (FLIPR) Assays

Fluorescence Imaging Plate Reader
Price on request

We have used FLIPR in a range of assay formats, readouts and target types including:

Antagonist and agonist screening in recombinant cell based assays
Working within 7-transmembrane receptor (7-TMR) receptor (also known as G-Protein Coupled Receptors or GPCR) biology for the last 15 years we have detailed knowledge and... Show more »

We have used FLIPR in a range of assay formats, readouts and target types including:

Antagonist and agonist screening in recombinant cell based assays
Working within 7-transmembrane receptor (7-TMR) receptor (also known as G-Protein Coupled Receptors or GPCR) biology for the last 15 years we have detailed knowledge and experience of developing assays and screening for 7-TMR activation and inhibition. We have used fluorescent methodologies with Fluo-3, Fluo-4, Fluo-4 no wash reagents and Fluo-5 in 96, 384 and 1536 well plates.

Show less

ic

Fluorescent Microvolume Assay Technology (FMAT)

Price on request

The 8200 Cellular Detection System (Fluorescent Microvolume Assay Technology – FMAT) from Applied Biosystems is a laser scanning macro-confocal fluorescent plate reader.

FMAT scans the central 1mm2 area of a micro well to a depth of 100μm from the base of the well using a red 633nm Helium-Neon laser to identify “objects” within... Show more »

The 8200 Cellular Detection System (Fluorescent Microvolume Assay Technology – FMAT) from Applied Biosystems is a laser scanning macro-confocal fluorescent plate reader.

FMAT scans the central 1mm2 area of a micro well to a depth of 100μm from the base of the well using a red 633nm Helium-Neon laser to identify “objects” within the focal plane. Objects such as cells or beads and associated fluorescence are detected and measured by two photomultiplier tubes (PMT1, 650-685 nm; PMT2, 685-720 nm) simultaneously. Fluorescence not associated with objects is undetected, so that the signal-to-noise ratio is dramatically increased. In addition, a 633nm excitation source reduces interference from the auto-fluorescence of compounds and plastic.

These features enable FMAT to perform homogeneous assays without the need to remove unbound label using time consuming washing steps that introduce significant assay variability.

Cell-based assays may be conducted on live or fixed cells with both adherent and suspension cell lines. Bead-based assays are also easy to perform and existing ELISAs are readily converted to homogeneous FMAT formats (FLISA) by coating beads with capture antibodies (Ref – J Biomol Screen March 2008 vol. 13 no. 3 210-217).

Show less

ic

High Content Screening

Price on request

High Content Screening (HCS) uses microscopic imaging to observe, measure and analyse multiple parameters within cells in a biological assay.

By using fluorescent dyes, fluorescently labelled proteins and fluorescently labelled antibodies, events that occur within cells following the addition of compounds and ligands can be... Show more »

High Content Screening (HCS) uses microscopic imaging to observe, measure and analyse multiple parameters within cells in a biological assay.

By using fluorescent dyes, fluorescently labelled proteins and fluorescently labelled antibodies, events that occur within cells following the addition of compounds and ligands can be detected and quantitated.
In addition to our in-house CellInsight CX5 platform, our scientists have access to the Image Xpress Ultra from the Molecular Devices Corporation.

Show less
Thermo Fisher Cx5 Human Hamster Mouse Rat project specific Oncology Rare Disease CNS/Neurology Cardiovascular Metabolism and Endocrinology Immuno-Oncology Diabetes Neurodegenerative diseases Autoimmune disease Fluorescent labeling live-cell imaging cell imaging Antibodies milligram Drug Discovery Toxicology project specific Large molecules/Biologics Show 24 more tags Show less

ic

Western Blot

Price on request

Aurelia Bioscience have invested in a Wes from ProteinSimple so as to provide a reliable automated western blotting service to clients.

Simple WesternTM Assay: The gel-free, blot-free, hands-free reinvention of Western blotting

Whilst Western blotting remains the pre-eminent method of choice for protein detection and... Show more »

Aurelia Bioscience have invested in a Wes from ProteinSimple so as to provide a reliable automated western blotting service to clients.

Simple WesternTM Assay: The gel-free, blot-free, hands-free reinvention of Western blotting

Whilst Western blotting remains the pre-eminent method of choice for protein detection and characterisation, the various improvements to individual aspects of Western work flow developed in recent years have had little impact on the relatively poor reproducibility, lack of accurate quantification, extensive time to result and reliability issues associated with traditional Western blotting.

The WesTM system from ProteinSimple is a fully automated device which runs the Simple Western size assay; a highly reproducible and sensitive alternative to standard Western blotting assays. Wes employs capillary electrophoresis combined with chemi-luminescence based antibody detection to run the entire Western immunoassay process from start to finish, providing dramatic improvements in sensitivity, reproducibility, quantitative accuracy and time to result compared to all other legacy Western blotting methods. Simple Western assays cover three separation ranges: 2 – 40kDa, 12 – 230 kDa and 66 – 440kDa.

Wes delivers exceptional results for virtually all sample types requiring a Western blotting approach. Minimal sample volume (3-5uL) at a low total protein concentration (0.2ug/uL) are required. Runs typically comprise 24 samples plus a size ladder and full results are generated in just over 3 hours. The Simple Western assay uses quality controlled proprietary consumables and all the client would ordinarily need to supply are their samples and a suitable primary antibody. An ever expanding wide range of Simple Western certified primary antibodies are available and primary antibodies from other sources may also be used.

In addition to Simple Western Immunoassay, Wes also runs the Simple Western Total Protein assay

Show less
ProteinSimple WES Human Rabbit Goat Mouse Rat Dog Non-human primates (NHP) project specific Oncology Rare Disease CNS/Neurology Cardiovascular Metabolism and Endocrinology Immuno-Oncology Diabetes Neurodegenerative diseases western blot Western blotting capillary separation Antibodies Proteins Biology Drug Discovery Toxicology project specific Large molecules/Biologics Show 27 more tags Show less

ic

Cell-Based Compound Screening

Price on request

Cell based assays are of key importance at a number of stages in the drug discovery process.

Being able to examine the interaction between your target and compounds in a cellular context is of great advantage in:

  • Mechanism of action studies
  • Identifying the potential for cytotoxicity
  • Defining the agonist or antagonist... Show more »

Cell based assays are of key importance at a number of stages in the drug discovery process.

Being able to examine the interaction between your target and compounds in a cellular context is of great advantage in:

  • Mechanism of action studies
  • Identifying the potential for cytotoxicity
  • Defining the agonist or antagonist properties of your compounds
  • Distinguish compounds that can cross the membrane of cells for intracellular target interactions

The team at Aurelia Bioscience have developed and screened using cell-based assays for over 15 years. Our knowledge and skills in cell culture and manipulation, combined with our expertise in developing cell-based assays allow us to work rapidly and efficiently on the prosecution of your target in appropriate assays.

Our core technology platform enables us to measure readouts such as fluorescence, luminescence and chemi-luminescence.

Example assays include but are not limited to:

  • Cytotoxicity measured using e.g. Resazurin, CellTiter-Glo, XTT
  • Second messenger and signal transduction assays e.g. cAMP accumulation, IP-one, b- arrestin activation
  • Reporter gene assays
  • Chemotaxis
  • Apoptosis
  • Cytokine release assays e.g. AlphaLisa
Show less
Perkin Elmer Enspire MD FLIPR Tetra Perkin Elmer EnVision ProteinSimple WES Human Hamster Mouse Rat Dog project specific Oncology Rare Disease CNS/Neurology Cardiovascular Respiratory Metabolism and Endocrinology Immuno-Oncology Diabetes Neurodegenerative diseases Flow cytometry Cell culture qPCR Cell-based assays cell imaging Cellular Compound Screening cellular uptake assays FLIPR Primary Cells Stem Cells Drug Discovery Client-specified membrane protein project specific Show 33 more tags Show less

ic

High Throughput Screening (HTS)

Price on request

With over 20 years of screening experience we are adept at designing screening assays and screening 100,000 to 1 million compounds in 384 well and 1536 well plates.

We have screened up to one million compounds in both cell and biochemical assays using a number of read outs including FLIPR, FMAT, FI, FRET, chemiluminescence,... Show more »

With over 20 years of screening experience we are adept at designing screening assays and screening 100,000 to 1 million compounds in 384 well and 1536 well plates.

We have screened up to one million compounds in both cell and biochemical assays using a number of read outs including FLIPR, FMAT, FI, FRET, chemiluminescence, luminescence and label-free formats.

We have extensive experience of cell-based assays in HTS where we have used either cell lines expressing the target in a recombinant manner, Bacmam transient expression and cryopreserved cells.

For human primary cell screening we have used either cryopreserved or freshly isolated cells such as PBMC’s and neutrophils. We understand the importance of delivering robust, reproducible assays with excellent quality control statistics for use in high throughput screening.

We are able to use our experience to assist your drug discovery projects in a number of ways:

  • we can validate your in-house assay for high throughput screening on our systems
  • we can adapt your assay for high throughput screening e.g. miniaturisation
  • we can develop a specific assay for your target, suitable for screening large numbers of compounds
  • we can run proof of concept or “tool” compound identification assays

Screening densities will be utilised which are consistent with the assay format and the number of compounds to be screened.

Show less
Perkin Elmer Enspire MD FLIPR Tetra Perkin Elmer EnVision Human Hamster Mouse Rat Dog project specific VARIOUS Oncology Rare Disease CNS/Neurology Cardiovascular Respiratory Metabolism and Endocrinology Immuno-Oncology Diabetes Neurodegenerative diseases Cytotoxicity alphaLISA Fluorescence Fluorescence Polarization bi-directional efflux assays DYNAMIC MASS REDISTRIBUTION FLIPR project specific Show 27 more tags Show less

ic

Biochemical Compound Screening

Price on request

Our team has extensive experience of developing and screening compounds in biochemical assays for a range of targets including but not limited to proteases, kinases, and phosphodiesterase enzymes and protein:protein interaction.

Our core technology platform enables us to offer fluorescence (Fluorescent Resonance Energy Transfer... Show more »

Our team has extensive experience of developing and screening compounds in biochemical assays for a range of targets including but not limited to proteases, kinases, and phosphodiesterase enzymes and protein:protein interaction.

Our core technology platform enables us to offer fluorescence (Fluorescent Resonance Energy Transfer [FRET], Fluorescent Intensity [FI], Time-Resolved Fluorescence [TRF]), AlphaScreen based chemiluminescence, luminescence and absorbance read outs to develop the best assay for your target needs.

Throughput is based on 96, 384 or 1536 well format giving the client the option to screen from 10’s to 100’s to 1000’s to millions of compounds. Screening approaches can be replicates of a single concentration for hit identification or multiple concentrations to generate assay response curves for structure activity profiling and compound progression.

We offer flexible services developing new assays or adapting existing assay to meet your needs e.g. incubation time, kinetic versus endpoint measurements etc.

Let us……

  • Consult on your target and the needs of your project
  • Design an assay with the appropriate readout for your target
  • Source reagents available in the marketplace or build custom reagents to requirements
  • Screen the assay in the most appropriate format using a robust, reliable approach
  • Maintain communication with you at each stage of the process
Show less

ic

Assay Development

Price on request

Development of biochemical and cell-based assays.

Development of biochemical and cell-based assays.

Show less

ic

qPCR

Quantitative PCR
Price on request

Aurelia Bioscience is now able to offer a qPCR service to our clients. Using our Applied Biosystems™ QuantStudio™ 6 Flex Real-Time PCR system, we are able to investigate quantitative differences in mRNA expression in relation to pathways and targets identified as being of interest to clients. The QuantStudio™ offers a high... Show more »

Aurelia Bioscience is now able to offer a qPCR service to our clients. Using our Applied Biosystems™ QuantStudio™ 6 Flex Real-Time PCR system, we are able to investigate quantitative differences in mRNA expression in relation to pathways and targets identified as being of interest to clients. The QuantStudio™ offers a high throughput real-time PCR platform (with a 384 well block) with sophisticated data analysis software. Designed to easily manage large data sets, the embedded gene expression study application can analyse >100 runs, while heat maps and scatter plots provide quick checks on data quality.

Show less

ic

Hit Identification

Price on request
Request a quote for more information about this service.

ic

DNA Services

Price on request
Request a quote for more information about this service.

ic

Drug Discovery & Development

Price on request
Request a quote for more information about this service.

ic

PCR

Price on request
Request a quote for more information about this service.

ic

Drug Discovery

Price on request
Request a quote for more information about this service.

ic

Protein Services

Price on request
Request a quote for more information about this service.

ic

Biochemistry & Molecular Biology

Price on request
Request a quote for more information about this service.

ic

Cell-Based Screening Methods

Price on request
Request a quote for more information about this service.

ic

Project Management

Price on request
Request a quote for more information about this service.

ic

Nucleic Acid Services

Price on request
Request a quote for more information about this service.

ic

Protein Expression Visualization

Price on request
Request a quote for more information about this service.

ic

Cells and Tissues

Price on request
Request a quote for more information about this service.

ic

Biology

Price on request
Request a quote for more information about this service.

ic

Cell and Tissue Culture

Price on request
Request a quote for more information about this service.

ic

Cell-Based Assays

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
Missing Avatar

Kevin Hart

Managing Director
FileType/PDF Created with Sketch.

Aurelia Bioscience 2017v3.pdf

Aurelia Bioscience Ltd has not received any reviews.

Aurelia Bioscience Ltd has not received any endorsements.